Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Neurobiol Aging. 2016 Apr 27;44:53–61. doi: 10.1016/j.neurobiolaging.2016.04.011

Fig 4.

Fig 4

Average percent change in 11C-PBR28 binding from baseline, overlaid on semi inflated cortical surface. Patients who showed clinical progression during the study interval (n = 9) had greater increases in 11C-PBR28 binding than non-progressors (n = 5) or controls (n = 8), with the greatest change observed in inferior temporal and parietal cortices.